scholarly journals Cost-Effectiveness of Mirabegron Compared with Tolterodine ER 4mg for the Treatment of Patients with Overactive Bladder in the United Kingdom: Results from a Trial-Based Model

2013 ◽  
Vol 16 (7) ◽  
pp. A633
Author(s):  
S. Aballéa ◽  
K. Maman ◽  
K. Desroziers ◽  
J. Nazir ◽  
I.A.O. Odeyemi ◽  
...  
Keyword(s):  
United Kingdom ◽  
Cost Effectiveness ◽  
Overactive Bladder ◽  
The United Kingdom ◽  
Tolterodine Er

scholarly journals Cost-Effectiveness of Mirabegron Compared with Antimuscarinics for the Treatment of Patients with Overactive Bladder in the United Kingdom

2013 ◽  
Vol 16 (7) ◽  
pp. A633-A634 ◽  
Author(s):  
K. Maman ◽  
M. Neine ◽  
B. Briquet ◽  
J. Nazir ◽  
I.A.O. Odeyemi ◽  
...  
Keyword(s):  
United Kingdom ◽  
Cost Effectiveness ◽  
Overactive Bladder ◽  
The United Kingdom

scholarly journals Cost Effectiveness of Mirabegron Compared with Tolterodine Extended Release for the Treatment of Adults with Overactive Bladder in the United Kingdom

2014 ◽  
Vol 35 (2) ◽  
pp. 83-93 ◽  
Author(s):  
Samuel Aballéa ◽  
Khaled Maman ◽  
Katia Thokagevistk ◽  
Jameel Nazir ◽  
Isaac A. O. Odeyemi ◽  
...  
Keyword(s):  
United Kingdom ◽  
Cost Effectiveness ◽  
Overactive Bladder ◽  
Extended Release ◽  
The United Kingdom

scholarly journals Cost-Effectiveness of Mirabegron Compared with Antimuscarinic Agents for the Treatment of Adults with Overactive Bladder in the United Kingdom

2015 ◽  
Vol 18 (6) ◽  
pp. 783-790 ◽  
Author(s):  
Jameel Nazir ◽  
Khaled Maman ◽  
Mohamed-Elmoctar Neine ◽  
Benjamin Briquet ◽  
Isaac A.O. Odeyemi ◽  
...  
Keyword(s):  
United Kingdom ◽  
Cost Effectiveness ◽  
Overactive Bladder ◽  
Antimuscarinic Agents ◽  
The United Kingdom

scholarly journals Cost-effectiveness of pazopanib versus sunitinib for metastatic renal cell carcinoma in the United Kingdom

PLoS ONE ◽  
2017 ◽  
Vol 12 (6) ◽  
pp. e0175920 ◽  
Author(s):  
Jordan Amdahl ◽  
Jose Diaz ◽  
Arati Sharma ◽  
Jinhee Park ◽  
David Chandiwana ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
United Kingdom ◽  
Cost Effectiveness ◽  
Cell Carcinoma ◽  
Metastatic Renal Cell Carcinoma ◽  
Renal Cell ◽  
The United Kingdom
Sign in / Sign up

Export Citation Format

Share Document